J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL) launches 360o Tobacco Cessation care on World No Tobacco Day.
‘NOSMOK®’ medicated nicotine lozenges for nicotine replacement therapy and AI-enabled Chatbot ‘‘Dr. Will’’ to help quit smoking.
Devika Nair 
J. B. Chemicals & Pharmaceuticals Ltd., (BSE: 506943, NSE: JBCHEPHARM), one of the fastest growing pharmaceutical companies in India today announced the launch of NOSMOK® prescription medicated nicotine lozenges as part of a 360o Tobacco Cessation initiative on ‘World No Tobacco Day’. NOSMOK® nicotine lozenges will help in reducing the urge to consume or smoke tobacco and relieve the psychological and psychomotor withdrawal symptoms and help them in their tobacco cessation journey. The medicated nicotine lozenges will be available in Mint flavour as sugar-based and sugar-free variants in 2mg and 4mg strengths. These lozenges are a part of the global JBCPL portfolio which are being introduced in India.
On this occasion, an AI-enabled Chatbot ‘Dr. Will’ has also been launched to encourage and support tobacco smokers to quit smoking and improve their quality of life. ‘Dr. Will’ is a comprehensive digital program that will help smokers in understanding their smoking triggers and motivate them to succeed in quitting. It will also support doctors in counselling smokers to quit the habit.
